160 related articles for article (PubMed ID: 11049029)
1. A new imaging technique for colorectal cancer: positron emission tomography.
Flamen P; Van Cutsem E; Mortelmans L
Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
[No Abstract] [Full Text] [Related]
2. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
3. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels.
Liu FY; Chen JS; Changchien CR; Yeh CY; Liu SH; Ho KC; Yen TC
Dis Colon Rectum; 2005 Oct; 48(10):1900-12. PubMed ID: 15991059
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography in colorectal cancer.
Flamen P
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
[TBL] [Abstract][Full Text] [Related]
5. The role of positron emission tomography in the management of colorectal cancer.
Tutt AN; Plunkett TA; Barrington SF; Leslie MD
Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of colorectal cancer with FDG-PET].
Uno K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
[No Abstract] [Full Text] [Related]
7. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Jörg L; Langsteger W
Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
[TBL] [Abstract][Full Text] [Related]
8. The role of positron emission tomography in the management of recurrent colorectal cancer: a review.
Watson AJ; Lolohea S; Robertson GM; Frizelle FA
Dis Colon Rectum; 2007 Jan; 50(1):102-14. PubMed ID: 17115340
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography and colorectal cancer.
Arulampalam TH; Costa DC; Loizidou M; Visvikis D; Ell PJ; Taylor I
Br J Surg; 2001 Feb; 88(2):176-89. PubMed ID: 11167864
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
[TBL] [Abstract][Full Text] [Related]
11. [18F-fluorodeoxyglucose positron emission tomography in colorectal cancer: value in primary staging and follow-up].
Jörg L; Heinisch M; Rechberger E; Kurz F; Klug R; Aufschnaiter M; Hammer J; Langsteger W
Acta Med Austriaca; 2002; 29(5):176-9. PubMed ID: 12506769
[TBL] [Abstract][Full Text] [Related]
12. Management of recurrent colorectal cancer with positron emission tomography.
Haji A
Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography imaging of colorectal cancer.
Akhurst T; Larson SM
Semin Oncol; 1999 Oct; 26(5):577-83. PubMed ID: 10528907
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Ruhlmann J; Schomburg A; Bender H; Oehr P; Robertz-Vaupel GM; Vaupel H; Wolter H; Kozak B; Biersack HJ
Dis Colon Rectum; 1997 Oct; 40(10):1195-204. PubMed ID: 9336115
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography/computed tomography in follow-up programmes for patients with colorectal cancer].
Hansen AF; Jensen MR; Nordholm-Carstensen A
Ugeskr Laeger; 2016 Sep; 178(37):. PubMed ID: 27649583
[TBL] [Abstract][Full Text] [Related]
16. Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Francis DL; Visvikis D; Costa DC; Croasdale I; Arulampalam TH; Luthra SK; Taylor I; Ell PJ
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):928. PubMed ID: 15034675
[No Abstract] [Full Text] [Related]
17. Decision analysis for the cost-effective management of recurrent colorectal cancer.
Park KC; Schwimmer J; Gambhir SS
Ann Surg; 2002 Feb; 235(2):309-10; author reply 310. PubMed ID: 11807375
[No Abstract] [Full Text] [Related]
18. Recent evidences of the use of 18F-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer.
Dias AR; Nahas SC; Camargo EE; Nahas CS
J Surg Educ; 2007; 64(2):114-9. PubMed ID: 17462214
[TBL] [Abstract][Full Text] [Related]
19. PET-scan in colorectal cancer.
Lonneux M
Acta Chir Belg; 2005 Aug; 105(4):333-7. PubMed ID: 16184712
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography as an adjunct to carcinoembryonic antigen in the management of patients with presumed recurrent colorectal cancer and nondiagnostic radiologic workup.
Zervos EE; Badgwell BD; Burak WE; Arnold MW; Martin EW
Surgery; 2001 Oct; 130(4):636-43; discussion 643-4. PubMed ID: 11602894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
